Sleep and the metabolic syndrome

Experimental Physiology

Volumn 92, Issue 1, 2007, Pages 67-78

  Wolk, Robert ^a,b   Somers, Virend K ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ABDOMINAL OBESITY; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; POPULATION; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SHIFT WORKER; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; STREPTOZOCIN DIABETES;

EID: 33846233354     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.033787     Document Type: Review

References (127)

1. Alberti KG & Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553.
2. Amir O, Alroy S, Schliamser JE, Asmir I, Shiran A, Flugelman MY, Halon DA & Lewis BS (2004). Brachial artery endothelial function in residents and fellows working night shifts. Am J Cardiol 93, 947-949.
3. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S & Hu FB (2003). A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26, 380-384.
4. Babu AR, Herdegen J, Fogelfeld L, Shott S & Mazzone T (2005). Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165, 447-452.
5. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J & Wallin BG (1993). Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763-1768.
6. Carlson JT, Rangemark C & Hedner JA (1996). Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14, 577-584.
7. Chin K, Kita H, Noguchi T, Otsuka N, Tsuboi T, Nakamura T, Shimizu K, Mishima M & Ohi M (1998). Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome. QJM 91, 627-633.
8. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M & Ohi M (2000). Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109, 562-567.
9. Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, Mishima M & Kuno K (1996). Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153, 1972-1976.
10. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K & Ohi M (1999). Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100, 706-712.
11. Ciftci TU, Kokturk O, Bukan N & Bilgihan A (2004). The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28, 87-91.
12. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM & Wilding JP (2004). Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25, 735-741.
13. D'Almeida V, Lobo LL, Hipolide DC, de Oliveira AC, Nobrega JN & Tufik S (1998). Sleep deprivation induces brain region-specific decreases in glutathione levels. Neuroreport 9, 2853-2856.
14. Di Lorenzo L, De Pergola G, Zocchetti C, L'Abbate N, Basso A, Pannacciulli N, Cignarelli M, Giorgino R & Soleo L (2003). Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obes Relat Metab Disord 27, 1353-1358.
15. Dyugovskaya L, Lavie P & Lavie L (2002). Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165, 934-939.
16. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D & Grant BJ (2002). Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121, 1541-1547.
17. Everson CA, Laatsch CD & Hogg N (2005). Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol 288, R374-R383.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults(2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
19. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M & Shimomura I (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761.
20. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK & Malaspina D (2006). Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 47, 833-839.
21. Gangwisch JE, Malaspina D, Boden-Albala B & Heymsfield SB (2005). Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28, 1289-1296.
22. Gonzalez-Ortiz M, Martinez-Abundis E, Balcazar-Munoz BR & Pascoe-Gonzalez S (2000). Effect of sleep deprivation on insulin sensitivity and cortisol concentration in healthy subjects. Diabetes Nutr Metab 13, 80-83.
23. Gopalakrishnan A, Ji LL & Cirelli C (2004). Sleep deprivation and cellular responses to oxidative stress. Sleep 27, 27-35.
24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA & Costa F (2006). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21, 1-6.
25. Guardiola JJ, Matheson PJ, Clavijo LC, Wilson MA & Fletcher EC (2001). Hypercoagulability in patients with obstructive sleep apnea. Sleep Med 2, 517-523.
26. Hampton SM, Morgan LM, Lawrence N, Anastasiadou T, Norris F, Deacon S, Ribeiro D & Arendt J (1996). Postprandial hormone and metabolic responses in simulated shift work. J Endocrinol 151, 259-267.
27. Harsch IA, Koebnick C, Wallaschofski H, Schahin SP, Hahn EG, Ficker JH, Lohmann T & Konturek PC (2004a). Resistin levels in patients with obstructive sleep apnoea syndrome - the link to subclinical inflammation? Med Sci Monit 10, CR510-CR515.
28. Harsch IA, Schahin SP, Bruckner K, Radespiel-Troger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T & Ficker JH (2004b). The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71, 252-259.
29. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC & Ficker JH (2004c). Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169, 156-162.
30. Harsch IA, Wallaschofski H, Koebnick C, Pour Schahin S, Hahn EG, Ficker JH & Lohmann T (2004d). Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71, 580-586.
31. Hertz R, Magenheim J, Berman I & Bar-Tana J (1998). Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 392, 512-516.
32. Hotamisligil GS, Shargill NS & Spiegelman BM (1993). Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91.
33. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC & Lam WK (2000a). Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162, 2166-2171.
34. Ip MS, Lam KS, Ho C, Tsang KW & Lam W (2000b). Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118, 580-586.
35. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW & Lam KS (2002). Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165, 670-676.
36. Karlsson B, Knutsson A & Lindahl B (2001). Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27485 people. Occup Environ Med 58, 747-752.
37. Karlsson BH, Knutsson AK, Lindahl BO & Alfredsson LS (2003). Metabolic disturbances in male workers with rotating three-shift work. Results of the WOLF study. Int Arch Occup Environ Health 76, 424-430.
38. Kato M, Phillips BG, Sigurdsson G, Narkiewicz K, Pesek CA & Somers VK (2000a). Effects of sleep deprivation on neural circulatory control. Hypertension 35, 1173-1175.
39. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V & Somers VK (2000b). Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102, 2607-2610.
40. Kitamura T, Onishi K, Dohi K, Okinaka T, Ito M, Isaka N & Nakano T (2002). Circadian rhythm of blood pressure is transformed from a dipper to a non-dipper pattern in shift workers with hypertension. J Hum Hypertens 16, 193-197.
41. Kjeldsen SE, Rostrup M, Moan A, Mundal HH, Gjesdal K & Eide IK (1992). The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol 20 (Suppl. 8), S32-S39.
42. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G & Olefsky JM (2002). Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87, 226-234.
43. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O'Donnell CP & Polotsky VY (2005a). Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99, 1643-1648.
44. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP & Polotsky VY (2005b). Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97, 698-706.
45. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G & Fogari R (1996). Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 9, 503-505.
46. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID & Evans JL (2001). Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of α-lipoic acid. Diabetes 50, 404-410.
47. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K & Sugimoto T (2006). Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64, 12-19.
48. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R & Yamasaki Y (1997). Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99, 144-150.
49. Meade TW, Chakrabarti R, Haines AP, North WR & Stirling Y (1979). Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1, 153-156.
50. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF & Mullington JM (2004). Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43, 678-683.
51. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M & Adachi M (2004). Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 126, 1473-1479.
52. Nagaya T, Yoshida H, Takahashi H & Kawai M (2002). Markers of insulin resistance in day and shift workers aged 30-59 years. Int Arch Occup Environ Health 75, 562-568.
53. Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE & Somers VK (1998a). Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 32, 1039-1043.
54. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG & Somers VK (1998b). Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97, 943-945.
55. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N & Somers VK (1999). Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99, 1183-1189.
56. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG & Quan SF (2001). Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154, 50-59.
57. Ogawa Y, Kanbayashi T, Saito Y, Takahashi Y, Kitajima T, Takahashi K, Hishikawa Y & Shimizu T (2003). Total sleep deprivation elevates blood pressure through arterial baroreflex resetting: a study with microneurographic technique. Sleep 26, 986-989.
58. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H & Ouchi Y (1999). Increased levels of circulating ICAM-1, VCAM-1, and l-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87, 10-14.
59. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T & Ouchi Y (2003). Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94, 179-184.
60. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M & Ouchi Y (2005). Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69, 221-226.
61. Peppard PE, Young T, Palta M, Dempsey J & Skatrud J (2000a). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284, 3015-3021.
62. Peppard PE, Young T, Palta M & Skatrud J (2000b). Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342, 1378-1384.
63. Phillips BG, Hisel TM, Kato M, Pesek CA, Dyken ME, Narkiewicz K & Somers VK (1999a). Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17, 1297-1300.
64. Phillips BG, Kato M, Narkiewicz K, Choe I & Somers VK (2000). Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279, H234-H237.
65. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME & Somers VK (1999b). Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17, 61-66.
66. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L & Perseghin G (2003). Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 26, 2883-2889.
67. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR & O'Donnell CP (2003). Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552, 253-264.
68. Polotsky VY, Wilson JA, Haines AS, Scharf MT, Soutiere SE, Tankersley CG, Smith PL, Schwartz AR & O'Donnell CP (2001). The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med 163, 624-632.
69. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA & O'Donnell CP (2003). Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136, 167-178.
70. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR & Smith PL (2002). Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165, 677-682.
71. Rajala MW, Obici S, Scherer PE & Rossetti L (2003). Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 111, 225-230.
72. Ramadan W, Petitjean M, Loos N, Geloen A, Vardon G, Delanaud S, Gros F & Dewasmes G (2006). Effect of high-fat diet and metformin treatment on ventilation and sleep apnea in non-obese rats. Respir Physiol Neurobiol 150, 52-65.
73. Ramanathan L, Gulyani S, Nienhuis R & Siegel JM (2002). Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport 13, 1387-1390.
74. Reaven GM (2006). The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83, 1237-1247.
75. Rebrin K, Steil GM, Mittelman SD & Bergman RN (1996). Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98, 741-749.
76. Robinson GV, Pepperell JC, Segal HC, Davies RJ & Stradling JR (2004). Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59, 777-782.
77. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H & Bashan N (1998). Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47, 1562-1569.
78. Saarelainen S, Seppala E, Laasonen K & Hasan J (1997). Circulating endothelin-1 in obstructive sleep apnea. Endothelium 5, 115-118.
79. Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C & Zidek W (2000). Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16, 648-652.
80. Sartipy P & Loskutoff DJ (2003). Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100, 7265-7270.
81. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S & Berthold HK (2002). Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122, 829-839.
82. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W & Grimminger F (2000a). Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162, 566-570.
83. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W & Grimminger F (2000b). Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55, 1046-1051.
84. Segal KR, Landt M & Klein S (1996). Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45, 988-991.
85. Sekine M, Yamagami T, Handa K, Saito T, Nanri S, Kawaminami K, Tokui N, Yoshida K & Kagamimori S (2002). A dose-response relationship between short sleeping hours and childhood obesity: results of the Toyama Birth Cohort Study. Child Care Health Dev 28, 163-170.
86. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V & Somers VK (2002). Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105, 2462-2464.
87. Sharifian A, Farahani S, Pasalar P, Gharavi M & Aminian O (2005). Shift work as an oxidative stressor. J Circadian Rhythms 3, 15.
88. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP & Dinges DF (2001). Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107, 165-170.
89. Shigeta H, Shigeta M, Nakazawa A, Nakamura N & Yoshikawa T (2001). Lifestyle, obesity, and insulin resistance. Diabetes Care 24, 608.
90. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, Kotani K, Nakamura T, Takemura K & Matsuzawa Y (1997). Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 241, 11-18.
91. Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, Marz W & Vassalli G (2004). Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47, 1574-1580.
92. Somers VK, Dyken ME, Clary MP & Abboud FM (1995). Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96, 1897-1904.
93. Spicuzza L, Bernardi L, Balsamo R, Ciancio N, Polosa R & Di Maria G (2006). Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome. Chest 130, 774-779.
94. Spiegel K, Leproult R, Colecchia EF, L'Hermite-Baleriaux M, Nie Z, Copinschi G & Van Cauter E (2000). Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am J Physiol Regul Integr Comp Physiol 279, R874-R883.
95. Spiegel K, Leproult R & Van Cauter E (1999). Impact of sleep debt on metabolic and endocrine function. Lancet 354, 1435-1439.
96. Spiegel K, Tasali E, Penev P & Van Cauter E (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141, 846-850.
97. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C & Tataranni PA (2003). Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 26, 3315-3319.
98. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C & Tataranni PA (2002). Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51, 1884-1888.
99. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA (2001). The hormone resistin links obesity to diabetes. Nature 409, 307-312.
100. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP & Somers VK (2005). Oxidative stress in obstructive sleep apnoea. Eur Heart J 26, 2435-2439.
101. Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ & Somers VK (2003). Serum amyloid A in obstructive sleep apnea. Circulation 108, 1451-1454.
102. Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S & Ip MS (2006). HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184, 377-382.
103. Tassone F, Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Grottoli S, Gai V, Ghigo E & Maccario M (2003). Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol (Oxf) 59, 374-379.
104. Tochikubo O, Ikeda A, Miyajima E & Ishii M (1996). Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 27, 1318-1324.
105. Uysal KT, Wiesbrock SM, Marino MW & Hotamisligil GS (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614.
106. VanHelder T, Symons JD & Radomski MW (1993). Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med 64, 487-492.
107. Vettor R, De Pergola G, Pagano C, Englaro P, Laudadio E, Giorgino F, Blum WF, Giorgino R & Federspil G (1997). Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 27, 1016-1024.
108. Vgontzas AN, Bixler EO & Chrousos GP (2003). Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254, 32-44.
109. Vgontzas AN, Bixler EO & Chrousos GP (2005). Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9, 211-224.
110. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A & Chrousos GP (2000). Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85, 1151-1158.
111. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K & Chrousos GP (1997). Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82, 1313-1316.
112. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G & Chrousos GP (1999). Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84, 2603-2607.
113. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G & Chrousos GP (2004). Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist. J Clin Endocrinol Metab 89, 4409-4413.
114. Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR & Ware JC (2005). Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165, 25-30.
115. Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N & Teschler H (2000). Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 162, 2039-2042.
116. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
117. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA & Prins JB (2006). Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8, 264-280.
118. Wilcox I, McNamara SG, Collins FL, Grunstein RR & Sullivan CE (1998). 'Syndrome Z': the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 (Suppl. 3), S25-S28.
119. Wolk R, Gami AS, Garcia-Touchard A & Somers VK (2005a). Sleep and cardiovascular disease. Curr Probl Cardiol 30, 625-662.
120. Wolk R, Shamsuzzaman AS & Somers VK (2003). Obesity, sleep apnea, and hypertension. Hypertension 42, 1067-1074.
121. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M & Somers VK (2005b). Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13, 186-190.
122. Yaggi HK, Araujo AB & McKinlay JB (2006). Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29, 657-661.
123. Yamasaki F, Schwartz JE, Gerber LM, Warren K & Pickering TG (1998). Impact of shift work and race/ethnicity on the diurnal rhythm of blood pressure and catecholamines. Hypertension 32, 417-423.
124. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T & Adachi M (2003). Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107, 1129-1134.
125. Young T, Palta M, Dempsey J, Skatrud J, Weber S & Badr S (1993). The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328, 1230-1235.
126. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P & Samet JM (2002). Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162, 893-900.
127. Zhang XL, Yin KS, Wang H & Su S (2006). Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 73, 73-77.